Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. - Lee,Y.P.; Schwarz,E.M.; Davies,M.; Jo,M.; Gates,J.; Zhang,X.; Wu,J.; Lieberman,J.R. (Cancer Res, 2002)